Bronchiolitis Obliterans, Lung Transplant Rejection
Conditions
Keywords
HRCT, High Resolution Computed Tomography scans, Functional Respiratory Imaging, FRI, Computed Tomography, CT, Bronchiolitis Obliterans, BOS, Lung Transplant
Brief summary
The objective of this study is to detect Bronchiolitis Obliterans Syndrome (BOS) in an early stage using the outcome parameters generated by Functional Respiratory Imaging (FRI). Robust and automated segmentation algorithms will be developed for these parameters, focusing on quantitative computed tomography (CT) image analyses to provide the physician a more sensitive diagnostics tool. The evolution of BOS over time will be monitored using non-rigid image registration methods.
Interventions
RADIATIONHigh Resolution Computed Tomography scan
a HRCT scan at Functional Residual Capacity (FRC) and Total Lung Capacity (TLC) will be taken on visit 1, visit 2, visit 3, visit 4 and visit 5. An Upper Airway (UA) scan will be taken on visit 1.
Sponsors
FLUIDDA nv
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male or female patient ≥ 18 years old * Written informed consent obtained * Patient who had undergone a lung transplant a year ago or more. * Female patient of childbearing potential who confirm that a contraception method was used at least 14 days before visit 1 and will continue to use a contraception method during the study * The patient must be able to perform the lung monitoring at home.
Exclusion criteria
* Pregnant or lactating female * Known history of or active airways or anastomotic complications requiring intervention such as stenting or dilation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Airway Resistance (iRaw) | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Airway Volume (iVaw) | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Specific Airway Volume (siVaw) | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Specific Airway Resistance (siRaw) | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Lobe volumes (iVlobes) | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Air trapping | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Internal Lobar Airflow Distribution | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Low Attenuation or Emphysema Score | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Blood Vessel Density or Fibrosis Score | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
| Airway Wall Thickness | 12 months | Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5. |
Countries
United States
Outcome results
None listed